clinicalomicsprowebdirectory
News
Topics
Precision Medicine
Translational Research
Molecular Dx
Informatics
Oncology
Patient Care
New Products
Magazine
Marketplace
Multimedia
Webinars
eBooks
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Search
Advertise
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Lead Generation Campaigns
Email Nurture Campaigns
Custom Content Solutions
About Us
Contact Us
Mary Ann Liebert Publishers
Create a Free Account
Log In
Clinical OMICs – Molecular Diagnostics in Precision Medicine
News
Coronavirus
Novavax Secures $1.6B in Funding for COVID-19 Vaccine Efforts
Precision Medicine
Study Finds Liquid Biopsy Insurance Coverage Growing but Incomplete
Bioinformatics
Illumina Intros Genomic Analysis Workflow Software to Speed Diagnosis of Genetic…
Precision Medicine
SpIntellx, CellNetix Partner To Validate Explainable AI Platform for Breast Cancer
Translational Research
Gut Microbiome Fluctuations Can Illuminate Type 2 Diabetes Risk
Topics
All
Precision Medicine
Translational Research
Molecular Dx
Informatics
Oncology
Patient Care
New Products
Coronavirus
Novavax Secures $1.6B in Funding for COVID-19 Vaccine Efforts
Precision Medicine
Study Finds Liquid Biopsy Insurance Coverage Growing but Incomplete
Bioinformatics
Illumina Intros Genomic Analysis Workflow Software to Speed Diagnosis of Genetic…
Precision Medicine
SpIntellx, CellNetix Partner To Validate Explainable AI Platform for Breast Cancer
Magazine
Magazine
Clinical OMICs Magazine Volume 7, Issue No. 3
Magazine
Clinical OMICs Magazine Volume 7, Issue No. 2
Magazine
Clinical OMICs Magazine Volume 7, Issue No. 1
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 6
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 5
Marketplace
Multimedia
All
Webinars
eBooks
Upcoming Webinars
Integrating NGS and Optical Mapping to Resolve Focal Amplifications in Cancer
On Demand Webinars
Newborn Genomic Screening: In Sickness and In Health
eBooks
Clinical Research in a Real-Time Sequencing Age
Precision Medicine
From Bench to Clinic—The Potential of New Sequencing Tools
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Home
Molecular Dx
Single-Cell Genomics
Single-Cell Genomics
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Single-Cell Genomics
Single-Cell Sequencing Provides Insights into Ovarian Cancer Subtypes
February 11, 2020
Single-Cell Genomics
10x Genomics More than Doubles Size of Planned IPO
September 3, 2019
Single-Cell Genomics
10x Genomics Graduates from ‘Super Success’ to $100M IPO
August 20, 2019
Single-Cell Genomics
Single-Cell Gene Expression Patterns Provide New MS Insights
July 22, 2019
Single-Cell Genomics
Response to Targeted Therapies Depends on Cancer Type
July 2, 2019
Single-Cell Genomics
New Targets Identified For Lupus and Rheumatoid Arthritis
June 19, 2019
Single-Cell Genomics
LabCorp’s Covance to Offer Services via Mission Bio’s Tapestri Platform
March 29, 2019
Single-Cell Genomics
Indivumed Parnters with IMCB on Asian Multiomics Cancer Database for Oncology
December 20, 2018
Single-Cell Genomics
With $30M Financing, Mission Bio Eyes Platform Development, Expansion into Gene...
December 13, 2018
Single-Cell Genomics
Every Spermatogenic Cell Sequenced, Informing Infertility and Contraception
November 7, 2018
Load more
Scroll Up
We use cookies to give you a better experience on clinicalomics.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![Centogene’s CentoMD® rare disease variant database will be integrated into Qiagen’s bioinformatics suite in a rare disease bioinformatics collaboration by the companies. [Source: alengo/Getty]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1291-218x150.jpeg "Illumina Intros Genomic Analysis Workflow Software to Speed Diagnosis of Genetic Conditions")
![Diagnostic firms are working to create new tests that can detect rheumatoid arthritis earlier and also provide risk assessment profiles of patients that are more or less likely to suffer permanent physical damage as a result of the disease. [©Puwadol Jaturawutthichai/Shutterstock]](https://www.clinicalomics.com/wp-content/uploads/2019/01/169-324x160.jpeg "New Targets Identified For Lupus and Rheumatoid Arthritis")
